Status: current, Defined. Date: 31-Aug 2018. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 2614281000168111 | Lignocaine (Pfizer) (lidocaine 20 mg / 1 g) gel, 10 g, syringe (containered trade product pack) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 2614291000168114 | Lignocaine (Pfizer) 2% gel, 10 g, syringe | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Lignocaine (Pfizer) 2% gel, 10 g, syringe | Is a | Lignocaine (Pfizer) 2% gel, 10 g | true | Inferred relationship | Some | ||
| Lignocaine (Pfizer) 2% gel, 10 g, syringe | Is a | containered trade product pack | true | Inferred relationship | Some | ||
| Lignocaine (Pfizer) 2% gel, 10 g, syringe | has TPUU | Lignocaine (Pfizer) 2% gel | true | Inferred relationship | Some | 1 | |
| Lignocaine (Pfizer) 2% gel, 10 g, syringe | has container type | syringe | true | Inferred relationship | Some | ||
| Lignocaine (Pfizer) 2% gel, 10 g, syringe | has TP | Lignocaine (Pfizer) | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Lignocaine (Pfizer) 2% gel, 10 x 10 g, syringes | has subpack | False | Lignocaine (Pfizer) 2% gel, 10 g, syringe | Inferred relationship | Some | 1 |
| Lignocaine (Pfizer) 2% gel, 10 x 10 g, syringes | has subpack | True | Lignocaine (Pfizer) 2% gel, 10 g, syringe | Inferred relationship | Some | 901136875 |
Reference Sets
Australian Register of Therapeutic Goods identifier reference set (foundation metadata concept)
Containered trade product pack reference set
FHIR